Testing effectiveness (Phase 2)Study completedNCT01430169
What this trial is testing
Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease
Who this might be right for
Peyronie's Disease
Endo USA Inc., a Keenova Therapeutics Company 20